Trials / Unknown
UnknownNCT03103191
Diagnostic Value of KL-6 in ILD
Diagnostic Value of KL-6 in Interstitial Lung Diseases
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (estimated)
- Sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
KL-6 may be a useful biomarker in patients with interstitial lung disease, but there is limited information in non-Asian populations. Therefore, it is necessary to carry out studies in other populations to confirm the diagnostic values of the biomarker and its prognostic implication. Hypothesis KL-6 may be a useful biomarker in the management of interstitial lung diseases. But it is necessary to know more about its utility in the European population. Study Objectives: * To determine the concentration of KL-6 in serum of patients with pulmonary fibrosis at the time of diagnosis compared to patients without pulmonary fibrosis * Diagnostic yield of KL-6 in patients with pulmonary fibrosis. * Correlation of KL-6 values with functional and radiological parameters of disease severity at diagnosis. * Correlation of serum KL-6 values with the evolution of the disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | KL-6 levels | Measure of KL-6 in serum |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2022-12-01
- Completion
- 2023-12-01
- First posted
- 2017-04-06
- Last updated
- 2020-08-18
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT03103191. Inclusion in this directory is not an endorsement.